دورية أكاديمية

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling.

التفاصيل البيبلوغرافية
العنوان: Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling.
المؤلفون: Alvarez, Nadine, Adam, Gregory C., Howe, John A., Sharma, Vijeta, Zimmerman, Matthew D., Dolgov, Enriko, Rasheed, Risha, Nizar, Fatima, Sahay, Khushboo, Nelson, Andrew M., Park, Steven, Zhou, Xiaoyan, Burlein, Christine, Fay, John F., Iwamoto, Daniel V., Bahnck-Teets, Carolyn M., Getty, Krista L., Lin Goh, Shih, Salhab, Imad, Smith, Keith
المصدر: Viruses (1999-4915); Jul2024, Vol. 16 Issue 7, p1158, 22p
مصطلحات موضوعية: SARS-CoV-2, MERS coronavirus, CORONAVIRUSES, GENETIC recombination, COVID-19 pandemic, LUNGS
مستخلص: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) continues to be a global threat due to its ability to evolve and generate new subvariants, leading to new waves of infection. Additionally, other coronaviruses like Middle East respiratory syndrome coronavirus (MERS-CoV, formerly known as hCoV-EMC), which first emerged in 2012, persist and continue to present a threat of severe illness to humans. The continued identification of novel coronaviruses, coupled with the potential for genetic recombination between different strains, raises the possibility of new coronavirus clades of global concern emerging. As a result, there is a pressing need for pan-CoV therapeutic drugs and vaccines. After the extensive optimization of an HCV protease inhibitor screening hit, a novel 3CLPro inhibitor (MK-7845) was discovered and subsequently profiled. MK-7845 exhibited nanomolar in vitro potency with broad spectrum activity against a panel of clinical SARS-CoV-2 subvariants and MERS-CoV. Furthermore, when administered orally, MK-7845 demonstrated a notable reduction in viral burdens by >6 log orders in the lungs of transgenic mice infected with SARS-CoV-2 (K18-hACE2 mice) and MERS-CoV (K18-hDDP4 mice). [ABSTRACT FROM AUTHOR]
Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19994915
DOI:10.3390/v16071158